Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cilgavimab (AZD-1061; COV2-2130), a humanized SARS-CoV-2-neutralizing monoclonal antibody, forms part of the monoclonal antibody combination AZD7442 with Tixagevimab. It demonstrates protective effects in mouse models of SARS-CoV-2 infection [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Cilgavimab (AZD-1061; COV2-2130), a humanized SARS-CoV-2-neutralizing monoclonal antibody, forms part of the monoclonal antibody combination AZD7442 with Tixagevimab. It demonstrates protective effects in mouse models of SARS-CoV-2 infection [1]. |
Molecular Weight | N/A |
CAS No. | 2420563-99-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cilgavimab 2420563-99-9 inhibitor inhibit